The kit is used to detect the neutralizing antibody to severe acute respiratory syndrome SARS-CoV-2 qualitatively. It is mainly used to identify individuals with acquired immune
response to the SARS-CoV-2, and to evaluate the effectiveness of the vaccine clinical trials and mass vaccination.
Features
3 steps to get results
Zero Cross-reactivity
Get results in 20mins
Specifications
Test Principle
Competitive inhibition method
Sample Type
Human serum,plasma or whole blood sample
Sample Volume
Whole blood 80~100ul
serum or plasma 60~80ul
Overall Percent Agreement
97.22%
Packing Specifications
1T/Kit, 5T/Kit, 10T/Kit
20T/Kit, 25T/Kit, 40T/Kit